
A new method could take the guesswork out of mixing drug cocktails
Synopsis:
A new model can predict drug interactions and side effects even between a large number of components
Drug cocktails such as those for treating cancer, like the alcoholic versions offered at the local bar, are best when the proper ingredients are mixed in the right proportions.
Like the cocktails we normally drink, the combination of ingredients can be better than the sum of its parts – or it can leave us with unwanted side effects.
A new model developed in the group of Prof. Uri Alon of the Weizmann Institute of Science’s Molecular Cell Biology Department can simplify the process of identifying the optimal blends for drug cocktails – even when a large number of ingredients is called for.
Drug cocktails – both antibiotic and anti-cancer – are increasingly used, among other things, because simultaneously attacking pathogenic cells with several different methods can reduce the risk of drug resistance.
Doctors and pharmaceutical companies are interested in the advance of drug “Mixology” because it can help create novel applications for existing drugs, since new ones are costly to develop and slow to reach the market.
Adding drugs together does not generally result just in the sum of their effects.
One drug can alert mechanisms in a cell that pump the other drugs out of the cell, thus changing the dose at which the other drugs will be effective.
Conversely, side effects can add up, so researchers often want to identify the lowest possible dose of any given drug.
With typically four or more drugs added together in chemotherapy cocktails, the number of possible combinations and doses is astronomical: It would be impossible to test them all to arrive at the optimal mix.
Because of the combinatorial explosion problem, say research students Anat Zimmer and Itay Katzir, who led the study, drug cocktails are often concocted without any good way of predicting the end result.
Their method requires only a small number of measurements on drug pairs.
The tests are conducted on human cancer cells or bacteria grown in lab dishes.
The group tested each drug – separately and in pairs – to understand the effects at several different doses.
This enabled the researchers to determine how drug A affects the actions of B, and vice versa, and the new mathematical model the group developed was then extrapolated to predict the interactions among three, four and more drugs in combination.
Further testing showed that the model performs better than existing methods of dealing with the combinatorial explosion problem.
Thus researchers using the model would not need to test every possible combination to arrive at the optimal doses in drug cocktails.
“There is an urgent demand for methods that can predict how drug cocktails will work,” says Katzir.
“This model may take much of the expensive guesswork out of the process of developing such cocktails.”
“The model might prove especially useful for personalized medicine – for example, in cancer – because each tumor can react differently to the same drugs,” adds Zimmer.
“It provides a way to mix that perfect cocktail without having to try out all of the possible combinations.”
Learn more: How to Mix the Perfect Cocktail
[osd_subscribe categories=’drug-interaction’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “DRUG INTERACTION”‘]
Receive an email update when we add a new DRUG INTERACTION article.
The Latest on: Drug interaction
[google_news title=”” keyword=”drug interaction” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug interaction
- Beyond OpenAI: 7 promising startups that have saved lives, sped up drug development and improved manufacturingon June 3, 2023 at 12:19 pm
ChatGPT-4 has become the focus of the AI wave, but other AI startups are emerging in fields including healthcare, education and manufacturing. Based on recent interviews with venture capitalists and ...
- Including African data in drug discovery and developmenton June 1, 2023 at 8:41 am
The low number of clinical trials in Africa and biomedical datasets that disproportionately represent populations of European ancestry contribute to the suboptimal efficacy and safety of some ...
- Using Machine Learning, Rohit Dixit Identifies Most Fatal Opioid Drug Interactions To Save Liveson May 31, 2023 at 7:12 pm
Within the rapidly evolving realm of artificial intelligence (AI), machine learning (ML) methods are gaining particular attention.
- Need help to quit smoking? A known drug might help reduce nicotine cravingson May 31, 2023 at 8:25 am
A drug that was originally developed to treat diabetes and severe overweight might also help people with nicotine dependence, concludes new research from the University of Copenhagen.
- Commonly used heart disease drugs may reduce the risk of post-stroke dementiaon May 31, 2023 at 6:00 am
Two drugs commonly used to treat heart problems could help improve cognitive function, including memory, after a lacunar stroke. Lacunar strokes are associated with a higher risk of cognitive ...
- Combining supplements with prescription drugs may cause treatment failure – Expertson May 27, 2023 at 6:01 pm
Pharmacists and physicians have said it is dangerous to indiscriminately take prescription drugs alongside dietary supplements without seeking advice or counselling from qualified healthcare personnel ...
- FDA warns about herbal drug kratom, used for pain relief: What to know about side effectson May 27, 2023 at 3:03 am
The FDA recently seized a large shipment of kratom. Here's what to know about the herbal drug and how it's used to treat pain and anxiety.
- BenchSci raises $70M to accelerate drug discovery with AIon May 26, 2023 at 10:53 am
Toronto-based artificial intelligence startup BenchSci has raised $95 million Canadian dollars, or $70 million, in funding to help scientists discover new drugs faster. BenchSci, officially Scinapsis ...
- FDA Approves First Oral Antiviral Drug for COVID-19on May 25, 2023 at 2:52 pm
The FDA has granted full approval to nirmatrelvir-ritonavir (Paxlovid) for treating adult outpatients with mild to moderate COVID-19 who are at risk for severe disease, the agency ...
via Bing News